Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$3.53bn	170.84	n/a
MSBMesoblast	AU$3.08bn	n/a	n/a
PYCPYC Therapeutics	AU$1.40bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.13bn	n/a	n/a
IMMImmutep	AU$576.85m	n/a	n/a
RACRacura Oncology	AU$385.71m	n/a	n/a
CGSCogstate	AU$366.57m	26.27	0.86%
DXBDimerix	AU$284.29m	n/a	n/a
PEBPacific Edge	NZ$229.98m	n/a	n/a
TTXTetratherix	AU$190.25m	n/a	n/a
ACWActinogen Medical	AU$133.44m	n/a	n/a
NYRNyrada	AU$122.33m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$109.04m	n/a	n/a
ALAArovella Therapeutics	AU$106.97m	n/a	n/a
BXNBioxyne	AU$97.42m	19.74	n/a
LTPLtr Pharma	AU$87.77m	n/a	n/a
ILAIsland Pharmaceuticals	AU$87.35m	n/a	n/a
CYPCynata Therapeutics	AU$81.34m	n/a	n/a
ATHAlterity Therapeutics	AU$73.02m	n/a	n/a
ATXAmplia Therapeutics	AU$64.13m	n/a	n/a